Comparing interval breast cancer rates in Norway and North Carolina: Results and challenges

Journal of Medical Screening

Volumn 16, Issue 3, 2009, Pages 131-139

  Hofvind, Solveig ^a   Yankaskas, Bonnie C ^b   Bulliard, Jean Luc ^c   Klabunde, Carrie N ^d   Fracheboud, Jacques ^e  

^a Cancer Registry of Norway ^*  (Norway)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d NATIONAL CANCER INSTITUTE   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER SCREENING; CANCER STAGING; FEMALE; FOLLOW UP; HEALTH CARE SYSTEM; HISTOPATHOLOGY; HUMAN; INTERVAL BREAST CANCER RATE; INTERVAL CANCER; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NORWAY; TUMOR VOLUME; UNITED STATES;

AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; NORTH CAROLINA; NORWAY;

EID: 70349954743     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/jms.2009.009012     Document Type: Article

References (31)

1. Yankaskas BC, Klabunde CN, Ancelle-Park R, et al. International comparison of performance measures for screening mammography: can it be done? J Med Screen 2004;11:187-193 (Pubitemid 40006742)
2. Klabunde CN, Sancho-Garnier H, Taplin S, Thoresen S, Ohuchi N, Ballard-Barbash R. Quality assurance in follow-up and initial treatment for screening mammography programs in 22 countries. Int J Qual Health Care 2002;14:449-461 (Pubitemid 36054418)
3. Bulliard JL, Sasieni P, Klabunde C, De Landtsheer JP, Yankaskas BC, Fracheboud J. Methodological issues in international comparison of interval breast cancer. Int J Cancer 2006;119:1158-1163 (Pubitemid 44116926)
4. Törnberg S, Codd M, Rodrigues V, Segnan N, Ponti A. Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: a collaborative study in four European centres. J Med Screen 2005;12:43-49 (Pubitemid 40445076)
5. Klabunde C, Bouchard F, Taplin S, Scharpantgen A, Ballard-Barbash R. Quality assurance for screening mammography: an international comparison. J Epidemiol Community Health 2001;55:204-212 (Pubitemid 32163569)
6. Hofvind S, Vacek P, Skelly J, Weaver D, Geller B. Comparing screening mammography for early breast cancer detection in Vermont and Norway. J Natl Cancer Inst 2008;100:1082-1091
7. Perry N, Broeders MJ, de Wolf C, Tornberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. Printed in Belgium. European Communities; 2006. http:// bookshop.eu.int ISBN: 92-79-01258-4. Assessed November 2008
8. Rosenberg RD, Yankaskas BC, Hunt WC, et al. Effect of variations in operational definitions on performance estimates for screening mammography. Acad Radiol 2000;7:1058-1068
9. Bordas P, Jonsson H, Nystrom L, Lenner P. Survival from invasive breast cancer among interval cases in the mammography screening programmes of northern Sweden. Breast 2007;16:47-54 (Pubitemid 46172856)
10. Vitak B, Olsen KE, Manson JC, Arnesson LG, Stal O. Tumour characteristics and survival in patients with invasive interval breast cancer classified according to mammographic findings at the latest screening: a comparison of true interval and missed interval cancers. Eur Radiol 1999;9:460-469
11. Hofvind S, Geller B, Vacek P, Thoresen S, Skaane P. Using the European Guidelines to evaluate the Norwegian Breast Cancer Screening Program. Eur J Epidemiol 2007;22:447-455 (Pubitemid 47222954)
12. Zackrisson S, Janzon L, Manjer J, Andersson I. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmo, Sweden 1976-1999. J Med Screen 2007;14:138-143
13. Broeders MJ, Scharpantgen A, Ascunce N, et al. Comparison of early performance indicators for screening projects within the European Breast Cancer Network: 1989-2000. Eur J Cancer Prev 2005;14:107-116
14. Smith-Bindman R, Ballard-Barbash R, Miglioretti DL, Patnick J, Kerlikowske K. Comparing the performance of mammography screening in the USA and the UK. J Med Screen 2005;12:50-54 (Pubitemid 40445077)
15. Yankaskas BC, Taplin SH, Ichikawa L, et al. Association between mammography timing and measures of screening performance in the United States. Radiology 2005;234:363-373 (Pubitemid 40139904)
16. The Ministry of Health and Social Affairs. Regulations on the collection and processing of personal health data in the Cancer Registry of Norway (Cancer Registry Regulations). Oslo, Norway, the Ministry of Health and Social Affairs, 2001
17. The Cancer Registry of Norway. Kvalitetsikring i Mammografiprogrammet. A Quality Assurance Manual for the Norwegian Breast Cancer Screening Program (in Norwegian). The Cancer Registry of Norway, Oslo, Norway, 2003
18. SEER (Surveillance Epidemiology and End Results). http://seer.cancer. gov/. Assessed November 2008
19. Yankaskas BC, Jones JA, Aldrich T. The Carolina Mammography Registry: A population-based mammography and cancer surveillance project. Journal Registry Management 1996;23:4
20. Department of Health and Human Services. Quality Mammography Standards. Final Rules-21 CRF Parts 16 and 900 (docket No. 95 N-0192) RIN 0910-AA24 edition. Washington DC, Department of Health and Human Services 1997; 55925-55926
21. U.S. Preventive Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med 2002;137(5 Part 1):344-346
22. American College of Radiology. Illustrated Breast Imaging Reporting and Data System (BI-RADS), 4th edn. American College of Radiology: Reston, VA, 2003
23. Larsen IK, Småstuen M, Johannesen TB, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009:1218-1231 Epub 2008 Dec 16
24. Hofvind S. Breast cancer screening-prevalence of disease in women who only respond after an invitation reminder. J Med Screen 2007;14:21-22 (Pubitemid 46440361)
25. Harvey SC, Geller B, Oppenheimer RG, Pinet M, Riddell L, Garra B. Increase in cancer detection and recall rates with independent double interpretation of screening mammography. AJR Am J Roentgenol 2003;180:1461-1467 (Pubitemid 36504645)
26. Taplin SH, Rutter CM, Elmore JG, Seger D, White D, Brenner RJ. Accuracy of screening mammography using single versus independent double interpretation. AJR Am J Roentgenol 2000;174:1257-1262 (Pubitemid 30261771)
27. Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003;39: 1718-1729 (Pubitemid 36897609)
28. Fracheboud J, de Koning HJ, Beemsterboer PM, et al. Interval cancers in the Dutch breast cancer screening programme. Br J Cancer 1999;81:912-917 (Pubitemid 29504707)
29. Hofvind S, Sørum R, Thoresen S. Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program. Acta Oncol 2007;47:225-231
30. Hofvind S, Bjurstam N, Sørum R, Bjorndal H, Thoresen S, Skaane P. Number and characteristics of breast cancer diagnosed in four periods in the screening interval of a biennial population based screening program. J Med Screen 2006;13:192-196 (Pubitemid 46057727)
31. Porter GJ, Evans AJ, Burrell HC, Lee AH, Ellis IO, Chakrabarti J. Interval breast cancers: prognostic features and survival by subtype and time since screening. J Med Screen 2006;13:115-122 (Pubitemid 44452722)